Dexcom | DXCM - 债务



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 34.99B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Align Technology USD 116.04M 1.6M 2026-03
AtriCure USD 71.78M 1.6M 2026-03
Baxter International USD 9.69B 93M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Cooper Companies USD 2.5B 5.6M 2025-12
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Globus Medical USD 115.22M 3.43M 2026-03
Inogen USD 0 0 2022-06
Insulet USD 948.4M 300K 2026-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 54.99B 7.05B 2026-03
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.56M 9K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06